regimes. It is found that relative to India, which had implemented process patent until 2005, China with a product patent … ; India …

protection. We use new survey data from India, the results of interviews with industry, government and multinational institutions …

This chapter discusses whether foreign investors, specifically pharmaceutical companies, could challenge India …'s regulatory measures that impact their patents under India's BITs. More specifically, the paper will focus on whether regulatory … expropriation under India's bilateral investment treaties (BITs). The discussion in the chapter shows that pharmaceutical patents …

India has charted its own intellectual property (IP) path over the last 35 years, attempting to foster the growth of a … international IP regime. Multinational companies (MNCs) have responded to India's movement towards compliance with WTO intellectual … the patenting and commercialization of new pharmaceutical products in India, waiting to see how Indian courts and patent …

protection. We use new survey data from India, the results of interviews with industry, government and multinational institutions …

developing countries in general with specification made to India. However significant changes brought about by the TRIPS … attention on the issue of compatibility with the TRIPS Agreement. India needs to achieve legal certainty by complying with the …